Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study
Introduction: Trastuzumab emtansine (T-DM1) is one of the effective treatment options in human epidermal growth factor receptor 2 (HER2) positive breast cancer patients. In this study, we aimed to find the effect of T-DM1 on survival, its tolerability and prognostic factors of T-DM1 treatment. Mate...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Emergency Department of Hospital San Pedro (Logroño, Spain)
2022-08-01
|
| Seri Bilgileri: | Iberoamerican Journal of Medicine |
| Konular: | |
| Online Erişim: | https://www.iberoamjmed.com/article/doi/10.53986/ibjm.2022.0033 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|